This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Instytut Immunologii I Terapii Doswiadczalnej Pan. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Mohamed Salah Omar Megahed
Introduction
Mohamed Salah Omar Megahed is an accomplished inventor based in Menoufia, Egypt. He has made significant contributions to the field of drug delivery systems, particularly through his innovative methods in producing polyanionic drug-carrier conjugates. His work focuses on enhancing the therapeutic properties of macromolecules, which can lead to improved medical treatments.
Latest Patents
One of his notable patents is titled "Method of production of polyanionic drug-carrier conjugates." This invention involves a unique method for creating a polyanionic macromolecule, which is a protein composed of polar amino acids such as lysine, arginine, aspartic acid, and glutamic acid. The innovation lies in the reaction between amine groups and the cyclic anhydride of dicarboxylic acid, resulting in a more negatively charged carrier. This modification enhances the therapeutic properties of the macromolecules, making them more effective in drug delivery applications. Mohamed holds 1 patent for this groundbreaking work.
Career Highlights
Mohamed Salah Omar Megahed is associated with the Institute of Immunology and Experimental Therapy, where he continues to advance his research in drug delivery systems. His expertise in the field has positioned him as a valuable contributor to the scientific community.
Collaborations
He has collaborated with notable colleagues, including Joanna Wietrzyk and Urszula Kańska, who share his passion for innovation in drug delivery and therapeutic applications.
Conclusion
In summary, Mohamed Salah Omar Megahed is a pioneering inventor whose work in polyanionic drug-carrier conjugates has the potential to revolutionize drug delivery systems. His contributions to the field are significant and reflect his dedication to improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile